Geneva, May 4 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123162) titled 'Effect of Ganagliflozin Proline Tablets on Cardiovascular Outcomes in Overweight or Obese Type 2 Diabetic Participates with Acute ST-segment Elevation Myocardial Infarction (STEMI) Undergoing Percutaneous Coronary Intervention (PCI): A Multicenter, Prospective, Single-arm study(GLOW-MI)' on April 22.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: The Third Affiliated Hospital Sun Yat-sen University
Condition:
ST-segment elevation myocardial infarction
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-05-01
Target Sample Size: Experimental group:180;...